MARKET

AGN

Allergan
AGN
NYSE
Delisted
P/E
P/S
P/B
MARKET CAP
-12.0477
3.947
1.090
63,651,343,951.74
Biogen: LAQEMBI's $10 Billion Potential
Biogen's latest alzheimer's drug, aduhelm, faced challenges after fda approval. The company's latest drug, a new type of alzheimer's treatment, has raised concerns. Biogen has a $10 billion potential, according to main street investor's analysis of the stock.
Seeking Alpha · 11/29/2023 20:00

Webull offers Allergan stock information, including NYSE: AGN real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, AGN stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading AGN stock methods without spending real money on the virtual paper trading platform.